Cellectar Biosciences financial statements
셀렉타 바이오사이언시스NASDAQ:CLRB · Nasdaq · Healthcare$1.78-4.81%
2026-10-02 closeCellectar Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$52M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy